background
mani
studi
inform
might
avail
whole
cohort
covari
even
outcom
might
ascertain
select
subsampl
studi
part
broad
categori
term
twophas
studi
common
exampl
includ
nest
casecontrol
casecohort
design
twophas
studi
appropri
weight
surviv
estim
deriv
howev
estim
cumul
incid
account
compet
event
propos
relev
presenc
multipl
type
event
estim
event
type
specif
quantiti
need
evalu
outcom
method
develop
non
parametr
estim
cumul
incid
function
event
account
possibl
compet
event
handl
gener
sampl
design
weight
deriv
sampl
probabl
varianc
deriv
influenc
function
subdistribut
hazard
result
propos
method
show
good
perform
simul
appli
estim
crude
incid
relaps
childhood
acut
lymphoblast
leukemia
group
defin
genotyp
avail
everyon
cohort
nearli
patient
death
due
toxic
act
compet
event
second
exampl
aim
estim
engag
care
cohort
hiv
patient
resourc
limit
set
patient
outcom
miss
due
lost
followup
sampl
base
approach
use
identifi
outcom
subsampl
lost
patient
obtain
valid
estim
connect
care
conclus
valid
estim
cumul
incid
event
account
compet
risk
gener
sampl
design
infinit
target
popul
deriv
mani
longitudin
studi
inform
might
measuredavail
whole
cohort
fact
biomarkersaddit
covari
even
outcom
might
ascertain
select
subsampl
studi
part
broad
categori
term
twophas
studi
fact
impli
two
sampl
phase
first
one
usual
random
sampl
target
popul
end
entir
cohort
phase
sampl
second
one
appli
kind
sampl
eg
effici
conveni
collect
addit
inform
select
subject
miss
data
expens
new
technolog
make
infeas
measur
biomark
entir
cohort
women
health
initi
program
exampl
store
serum
plasma
particip
use
special
studi
also
cardiovascular
health
studi
collect
dna
particip
studi
differ
genet
factor
underli
cardiovascular
diseas
subset
cohort
genotyp
differ
project
first
motiv
clinic
exampl
aim
evalu
role
differ
genet
polymorph
treatment
failur
due
relaps
childhood
acut
lymphoblast
leukemia
use
clinic
inform
biolog
sampl
avail
clinic
trial
enrol
nearli
patient
situat
parsimoni
use
specimen
motiv
choic
efficientoptim
twophas
sampl
design
present
also
applic
aim
estim
engag
care
hiv
patient
resourc
limit
set
outcom
miss
group
patient
due
possibl
inform
loss
followup
outcom
track
random
sampl
lost
followup
obtain
valid
estim
engag
care
twophas
studi
appropri
weight
surviv
estim
deriv
presenc
addit
covari
measur
second
phase
well
cohort
outcomefollowup
avail
everyon
cox
model
adapt
twophas
design
also
deriv
howev
estim
cumul
incid
account
compet
event
gener
framework
twophas
design
propos
develop
specif
design
nest
casecontrol
studi
relev
presenc
multipl
type
event
relaps
toxic
death
cancer
patient
motiv
exampl
present
estim
event
type
specif
quantiti
need
evalu
outcom
aim
paper
develop
non
parametr
estim
crude
incid
event
account
possibl
compet
event
gener
framework
twophas
design
subgroup
analysi
might
defin
accord
explanatori
variabl
ascertain
phase
ii
sampl
outcom
assess
second
phase
sampl
method
section
propos
weight
crude
incid
estim
applic
twophas
design
theoret
properti
propos
method
deriv
appendix
investig
simul
differ
scenario
result
report
result
section
section
also
report
exampl
childhood
hiv
patient
conclus
dedic
discuss
let
failur
time
variabl
suppos
k
possibl
caus
failur
denot
k
let
causespecif
hazard
function
k
th
event
probabl
failur
due
caus
k
occur
time
quantiti
aim
estim
defin
also
p
k
f
k
probabl
surviv
caus
failur
conveni
represent
crude
incid
function
product
limit
estim
natur
aris
start
subdistribut
hazard
introduc
gray
defin
hazard
shown
use
compar
crude
cumul
hazard
function
differ
group
sinc
restor
onetoon
relationship
hazard
cumul
probabl
particular
failur
type
ds
product
integr
notat
use
suggest
limit
finit
product
note
onetoon
relationship
hazard
cumul
probabl
satisfi
causespecif
hazard
presenc
compet
event
subdistribut
hazard
thought
hazard
artifici
variabl
k
k
k
extend
infin
time
event
k
anoth
compet
event
observ
fact
finit
k
equival
k
thu
given
definit
definit
k
consist
argument
event
k
occur
first
latter
never
observ
first
thu
correspond
time
infin
let
n
independ
replic
c
z
c
censor
time
z
vector
covari
refer
n
subject
phase
sampl
defin
x
min
c
c
assum
failur
censor
time
condit
independ
indic
function
defin
g
p
c
probabl
remain
uncensor
suppos
complet
inform
x
z
avail
subset
n
n
subject
drawn
base
possibl
complex
sampl
design
let
indic
whether
subject
select
sampl
refer
n
subject
phase
ii
sampl
even
multipl
phase
sampl
could
actual
involv
obtain
final
complet
sampl
let
p
z
inclus
probabl
subject
phase
ii
sampl
condit
select
first
phase
random
sampl
probabl
equal
everi
subject
howev
sampl
often
stratifi
variabl
increas
effici
case
probabl
select
phase
ii
sampl
common
subject
stratum
differ
strata
particular
usual
higher
inform
strata
eg
strata
includ
subject
event
interest
casecontrol
studi
nest
casecontrol
design
sampl
probabl
case
one
control
might
deriv
probabl
individu
ever
select
control
follow
samuelsen
denot
pairwis
sampl
probabl
two
subject
j
commonli
assum
survey
theori
sampl
method
follow
properti
sampl
probabl
ij
must
non
zero
j
popul
must
known
j
sampl
twophas
design
common
interest
estim
surviv
subgroup
relat
variabl
ascertain
phase
ii
sampl
ie
biomark
anoth
possibl
situat
instead
covari
outcom
avail
whole
cohort
thu
case
estim
incid
event
use
phase
ii
sampl
use
total
number
event
type
k
total
number
person
risk
time
entir
phase
sampl
estim
phase
ii
sampl
account
sampl
design
byn
respect
note
estim
valid
gener
sampl
design
ij
socal
design
weight
known
observ
actual
sampl
estim
overal
surviv
shown
sever
author
differ
context
complex
sampl
overal
hazard
obtain
shown
n
converg
weakli
zeromean
gaussian
process
goal
estim
crude
incid
given
caus
k
f
k
k
ds
use
phase
ii
sampl
also
call
subdistribut
function
probabl
failur
due
caus
k
occur
within
estim
k
base
count
event
due
caus
k
count
subject
risk
k
denot
see
appendix
estim
cumul
subdistribut
hazard
estim
use
phase
ii
sampl
note
complement
f
k
thought
surviv
probabl
k
thu
product
limit
type
estim
directli
deriv
interestingli
estim
algebra
equival
aalenjohansen
type
estim
shown
random
sampl
appendix
gener
sampl
easi
see
absenc
compet
event
degener
usual
risk
k
andf
k
equal
complement
weight
kaplanmei
estim
twophas
studi
censor
x
becom
risk
set
erod
time
event
type
k
thereforef
k
degener
proport
event
type
k
estim
phase
ii
sampl
weight
number
event
type
k
estim
total
size
cohort
phase
everi
subject
phase
sampl
becom
standard
subdistribut
cumul
hazard
standard
estim
crude
incid
simplic
notat
estim
overal
incid
regardless
covari
estim
also
appli
subgroup
defin
z
censor
probabl
g
also
estim
subgroup
defin
z
overal
estim
reason
make
restrict
assumpt
c
otherwis
separ
estim
condit
z
would
appropri
eventu
averag
weight
frequenc
z
condit
estim
follow
breslow
wellner
express
repres
crude
cumul
incid
estim
would
obtain
complet
inform
x
z
known
subject
phase
sampl
n
two
term
asymptot
independ
first
term
converg
weakli
zeromean
gaussian
process
covari
denot
ki
argument
appendix
second
term
converg
weakli
zeromean
gaussian
process
covari
kii
henc
converg
weakli
zeromean
gaussian
process
covari
sum
contribut
sampl
phase
first
one
repres
irreduc
minimum
uncertainti
would
remain
everyon
phase
would
sampl
second
one
account
fact
complet
inform
avail
phase
ii
sampl
contribut
varianc
estim
influenc
function
approach
influenc
function
estim
describ
estim
chang
singl
observ
ad
remov
data
properti
differ
estim
popul
quantiti
express
sum
influenc
function
subject
sampl
denot
z
ik
influenc
function
subject
k
influenc
function
subject
k
deriv
appendix
use
horvitzthomposon
varianc
weight
influenc
function
contribut
varianc
phase
ii
phase
ki
also
estim
use
set
sampl
probabl
given
onetoon
relationship
f
k
k
varianc
crude
cumul
incid
estim
analog
surviv
estim
twophas
design
deriv
confid
interv
logarithm
scale
q
denot
quantil
standard
gaussian
distribut
use
suitabl
weight
studi
design
censor
softwar
allow
time
depend
weight
use
deriv
modifi
risk
set
estim
crude
cumul
incid
function
weight
implement
r
function
crprep
mstate
packag
stata
stcrprep
function
howev
softwar
use
deriv
ingredi
modifi
risk
set
use
estim
varianc
horvitzthompson
approach
complet
code
comput
estim
develop
r
softwar
use
survey
packag
avail
exampl
applic
function
given
subsect
genotyp
ascertain
subset
clinic
trial
cohort
consid
two
compet
event
independ
latent
time
constant
margin
hazard
crude
incid
focus
crude
incid
event
unit
time
ie
year
impli
fraction
event
administr
censor
crude
incid
independ
latent
time
restrict
given
non
identifi
issu
censor
time
follow
uniform
distribut
rang
lead
around
censor
respect
drew
b
random
firstphas
sampl
size
n
sampl
phase
ii
sampl
accord
differ
studi
design
random
sampl
n
unit
casecontrol
sampl
randomli
sampl
individu
among
experienc
event
case
time
individu
among
other
control
n
unit
stratifi
sampl
consid
phase
sampl
divid
strata
defin
variabl
z
frequenc
z
z
respect
occurr
event
time
hazard
rate
assum
z
z
respect
equal
number
subject
sampl
strata
balanc
sampl
n
unit
nest
casecontrol
design
select
case
control
case
event
time
event
case
fix
design
fix
total
sampl
size
priori
expect
around
event
control
sampl
probabl
includ
subject
deriv
accord
samuelsen
b
chosen
order
get
level
accuraci
estim
crude
incid
f
sampl
sampl
f
comput
dt
estim
compar
f
order
assess
bia
sampl
bia
comput
report
differ
time
point
simul
also
comput
standard
error
accord
confid
interv
ci
logarithm
scale
evalu
coverag
length
figur
compar
averag
estim
standard
error
simul
empir
standard
error
differ
time
observ
four
differ
scenario
random
censor
found
close
scenario
expect
figur
report
distribut
bia
one
simul
sampl
random
panel
casecontrol
panel
b
stratifi
panel
c
nest
casecontrol
sampl
panel
bia
fluctuat
around
scenario
variabl
random
sampl
compar
scenario
result
also
higher
mean
valu
absolut
bia
b
simul
still
alway
lower
lower
perform
estim
first
scenario
due
fact
random
sampl
conveni
design
simul
set
fact
phase
cohort
expect
around
event
type
incid
sampl
size
thu
randomli
sampl
subject
phase
cohort
expect
observ
event
phase
ii
sampl
small
number
event
unbiased
fact
suffici
ensur
reason
behaviour
get
enough
inform
event
incid
address
issu
studi
design
scenario
inde
thought
guarante
sampl
event
type
thu
recommend
adopt
effici
design
account
event
interest
rel
standard
bias
alway
lower
data
shown
mean
squar
error
shown
slightli
increas
time
fact
variabl
increas
time
confirm
empir
standard
error
fig
averag
length
confid
interv
consist
increas
time
rang
random
sampl
casecontrol
stratifi
nest
casecontrol
sampl
data
shown
comparison
underscor
advantag
care
select
subsampl
figur
report
result
coverag
random
casecontrol
stratifi
nest
casecontrol
sampl
coverag
close
nomin
valu
rang
mostli
within
minimum
maximum
except
earli
time
random
set
set
also
consid
longer
followup
time
around
event
type
expect
phase
sampl
censor
confirm
perform
estim
scenario
higher
variabl
similar
result
differ
sampl
scheme
data
shown
studi
childhood
evalu
role
genet
polymorph
glutathion
treatment
failur
due
relaps
differ
site
presenc
compet
event
toxic
death
common
genet
polymorph
caucasian
individu
display
homozyg
delet
gene
null
genotyp
subject
carri
null
variant
fail
express
enzym
involv
drug
metabol
clinic
inform
avail
cohort
consecut
patient
mainli
european
caucasian
age
year
median
age
year
newli
diagnos
italian
associazion
italiana
di
ematologia
pediatrica
center
septemb
juli
biolog
sampl
store
diagnosi
avail
genotyp
ascertain
subgroup
phase
ii
sampl
effici
use
specimen
interest
evalu
incid
differ
relaps
site
estim
use
phase
ii
data
order
select
subgroup
genotyp
adopt
optim
strategi
care
describ
briefli
sampl
done
classifi
patient
strata
accord
event
interest
relapseno
relaps
group
defin
prognost
featur
treatment
protocol
modul
intens
treatment
call
panel
first
three
scenario
sampl
size
use
nest
casecontrol
sampl
mean
subject
consid
data
subject
random
censor
plu
administr
censor
dash
line
repres
main
bisector
correspond
equal
estim
empir
refer
treatment
protocol
tabl
strata
defin
base
compet
event
death
due
event
effici
reason
given
event
interest
relaps
patient
sampl
random
without
replac
strata
sampl
stratum
conduct
independ
stratifi
sampl
higher
probabl
inform
strata
accord
optim
design
full
cohort
patient
repres
phase
sampl
clinic
inform
avail
genotyp
ascertain
phase
ii
sampl
n
relaps
classifi
accord
site
particular
distinguish
relaps
involv
bonemarrow
bm
other
extramedullari
estim
crude
incid
bm
relaps
delet
use
found
higher
relaps
incid
patient
delet
crude
incid
fig
panel
deriv
account
compet
risk
site
relaps
well
death
due
toxic
report
r
code
use
comput
estim
librari
survey
dstd
twophas
idlist
isna
gstt
stratalist
null
rel
elfin
datadat
gstse
svycr
surv
time
event
etyp
bmrelaps
dstd
setru
twophas
function
survey
packag
describ
design
produc
survey
object
svycr
function
avail
perform
estim
crude
incid
influenc
approach
use
variabl
time
time
event
event
censor
indic
event
type
observ
otherwis
bmrelaps
indic
whether
bm
relaps
observ
detail
survey
packag
found
panel
first
three
scenario
sampl
size
use
nest
casecontrol
sampl
mean
subject
consid
data
subject
random
censor
administr
censor
box
repres
first
third
quartil
black
line
median
empti
dot
repres
outlier
defin
bia
time
interquartil
rang
third
quartil
time
interquartil
rang
first
quartil
dot
line
repres
refer
bia
bia
equal
right
panel
fig
repres
incid
extramedullari
relaps
show
differ
relaps
incid
delet
patient
mainli
due
relaps
involv
bm
repres
relev
type
relaps
childhood
cox
model
adapt
twophas
design
appli
caus
specif
hazard
bm
relaps
give
hazard
ratio
hr
ci
delet
patient
versu
non
delet
adjust
relev
factor
treatment
protocol
gender
age
hr
drop
ci
extramedullari
relaps
hr
ci
note
order
compar
patient
without
delet
gene
use
causespecif
model
thu
actual
compar
causespecif
hazard
relaps
fact
subdistribut
model
account
twophas
design
avail
would
use
compar
actual
incid
relaps
two
group
howev
causespecif
model
still
use
address
impact
genotyp
relaps
aetiolog
point
view
evalu
effect
global
effort
provid
antiretrovir
therapi
art
hivinfect
patient
resourc
limit
set
estim
number
patient
continu
access
care
start
art
essenti
estim
hamper
howev
fact
patient
die
shortli
last
visit
clinic
group
individu
consid
stop
care
censor
event
stop
care
addit
number
patient
start
care
larg
high
fraction
unknown
outcom
ie
lost
followup
gener
inform
censor
given
lost
patient
could
reason
care
could
also
chang
clinic
panel
first
three
scenario
sampl
size
use
nest
case
control
sampl
mean
subject
consid
data
subject
random
censor
administr
censor
dot
line
repres
refer
ci
coverag
nomin
dead
one
approach
obtain
outcom
estim
identifi
numer
small
random
sampl
lost
intens
seek
outcom
use
correct
outcom
among
lost
illustr
cohort
hivinfect
adult
patient
initi
art
treatment
follow
art
initi
either
death
disengag
administr
databas
closur
see
fig
among
patient
lost
followup
defin
seen
clinic
least
day
last
return
visit
tracker
went
commun
determin
outcom
random
subsampl
among
lost
patient
got
inform
patient
patient
found
care
clinic
die
care
found
treateddisengag
patient
lost
followup
track
patient
consid
second
phase
sampl
whole
cohort
stratifi
lost
followup
use
method
develop
method
section
estim
crude
cumul
incid
track
patient
repres
lost
patient
fig
crude
cumul
incid
relaps
data
panel
report
crude
cumul
incid
estim
relaps
involv
bone
marrow
patient
normal
estim
confid
limit
report
solid
line
delet
dash
line
gene
panel
b
report
crude
cumul
incid
estim
relaps
extramedullari
site
patient
normal
solid
line
delet
dash
line
gene
sampl
probabl
sampl
weight
one
crude
incid
estim
disengag
report
fig
curv
start
rise
day
art
start
earliest
possibl
time
disengag
definit
year
disengag
result
ci
subject
strong
influenc
compet
event
death
care
result
ci
year
less
expens
approach
deal
inform
censor
would
treat
lost
patient
event
contrarili
censor
observ
plot
two
correspond
curv
fig
obtain
estim
crude
incid
year
sinc
art
treatment
respect
consid
true
incid
lie
two
estim
howev
quit
far
context
fact
r
code
comput
propos
estim
crude
cumul
incid
avail
result
simul
present
simul
section
relat
code
also
avail
deriv
estim
cumul
incid
event
base
subdistribut
hazard
account
compet
risk
gener
sampl
design
infinit
target
popul
estim
show
good
perform
simul
differ
scenario
varianc
deriv
influenc
function
subdistribut
hazard
horvitzthompson
theori
close
empir
varianc
therefor
expect
close
one
obtain
replic
weight
eg
bootstrap
confid
interv
deriv
log
scale
provid
good
coverag
simul
altern
confid
interv
might
also
consid
complementari
loglog
transform
propos
estim
use
estim
incid
relaps
genotyp
cohort
childhood
patient
genotyp
ascertain
subsampl
cohort
chosen
optim
sampl
approach
base
relaps
event
interest
interestingli
also
analyz
incid
compet
event
toxic
death
combin
endpoint
relaps
toxic
death
effici
could
lower
unless
subsampl
adapt
new
endpoint
includ
strata
toxic
death
sampl
process
particularli
import
sinc
toxic
death
rare
event
context
also
rememb
avoid
random
sampl
event
interest
rare
discuss
simul
section
second
case
dealt
miss
data
problem
outcom
avail
everybodi
sinc
patient
lost
followup
subsampl
lost
patient
track
ascertain
outcom
track
possibl
approach
deal
inform
censor
could
identifi
variabl
affect
missing
poststratifi
sampl
homogen
strata
use
miss
probabl
strata
sort
sampl
weight
adjust
incid
estim
approach
would
make
import
assumpt
miss
random
might
appropri
test
howev
underlin
propos
estim
could
appli
also
presenc
miss
data
code
comput
estim
develop
r
softwar
survey
packag
avail
survey
packag
flexibl
packag
complex
survey
includ
also
twophas
studi
provid
flexibl
function
describ
design
studi
deriv
sampl
fraction
accordingli
packag
includ
function
estim
surviv
perform
weight
cox
model
standard
error
properli
adjust
design
possibl
use
gener
weight
calibr
weight
function
take
advantag
facil
packag
see
exampl
use
genotyp
ascertain
subset
clinic
trial
cohort
order
recov
repres
subcohort
phase
ii
entir
cohort
use
weight
relat
invers
probabl
sampl
similarli
weight
barlow
casecohort
studi
gener
weight
use
calibr
weight
use
calibr
weight
advantag
avail
phase
variabl
strongli
relat
addit
variabl
ascertain
phase
ii
would
provid
result
repres
phase
data
increas
precis
phase
ii
variabl
common
genet
polymorph
first
exampl
unlik
find
strong
relat
phase
ii
variabl
therefor
big
advantag
would
expect
calibr
estim
also
extend
situat
individu
may
move
among
finit
number
state
estim
aalenjohansen
probabl
transit
among
state
multist
framework
presenc
gener
sampl
design
order
deriv
modelbas
estim
incid
adjust
possibl
covari
two
main
approach
follow
context
compet
risk
first
one
base
causespecif
hazard
inspir
benich
gail
one
base
subdistribut
hazard
crude
cumul
estim
develop
kovalchik
pfeiffer
twophas
studi
finit
popul
follow
first
approach
cox
model
twophas
design
could
use
extend
infinit
popul
model
estim
effect
covari
causespecif
hazard
address
impact
event
aetiolog
point
view
howev
well
known
reflect
impact
variabl
crude
cumul
incid
latter
effect
even
affect
incid
compet
event
could
still
interest
public
health
prospect
futur
work
concern
develop
regress
model
assess
effect
covari
crude
cumul
incid
fine
gray
regress
model
could
extend
complex
sampl
weight
estim
function
paramet
interest
work
influenc
function
deriv
risk
set
k
risk
set
usual
surviv
time
commonli
obtain
standard
analysi
count
observ
time
greater
also
written
probabl
free
censor
estim
consid
censor
observ
event
viceversa
accord
prove
also
case
twophas
design
follow
wheren
c
denot
number
censor
time
andn
n
total
count
event
observ
time
deriv
risk
set
k
obtain
writingf
l
empir
cumul
distribut
functionf
l
risk
set
becom
simplifi
equival
first
summat
estim
usual
total
number
subject
risk
condit
x
min
c
satisfi
fact
impli
min
ki
c
ie
risk
impli
also
risk
k
second
summat
estim
number
subject
event
satisfi
condit
x
min
c
k
impli
ki
complet
number
risk
k
first
part
expos
censor
contribut
subject
observ
fail
caus
l
k
l
k
n
il
would
remain
equal
thu
ignor
possibl
censor
given
c
usual
observ
c
possibl
way
deal
inconsist
mimic
presenc
random
censor
act
infinit
time
weight
unitari
weight
assum
valu
x
decreas
afterword
accord
censor
distribut
note
altern
express
deriv
show
upweight
multipli
get
greater
action
compet
event
get
larger
account
fact
subject
experienc
event
type
l
k
never
experi
event
k
first
equal
cumul
incid
artifici
variabl
aalenjohansen
type
estim
purpos
proof
denot
asf
aj
k
hold
true
prove
induct
quantiti
step
function
chang
valu
occurr
type
k
event
time
first
event
type
k
observ
k
dt
k
dt
first
event
overal
eq
assum
hold
true
given
impliesf
aj
k
f
k
use
equal
prove
lin
show
normalis
horvitzthompson
estim
number
event
asymptot
multivari
zeromean
normal
firstli
concentr
normalis
horvitzthompson
estim
modifi
risk
process
first
term
repres
estim
number
risk
lin
show
asymptot
multivari
zeromean
normal
concentr
second
term
use
lemma
also
converg
zeromean
gaussian
process
want
prove
also
converg
zeromean
normal
k
repres
crude
cumul
incid
estim
would
obtain
complet
inform
x
z
known
subject
phase
sampl
n
fine
gray
prove
first
term
converg
weakli
zeromean
gaussian
process
second
term
result
follow
also
n
k
k
converg
weakli
zeromean
gaussian
process
k
express
differenti
function
g
estim
total
number
event
type
k
total
number
risk
w
indic
whether
subject
withdrawn
phase
ii
sampl
differ
true
estim
cumul
hazard
express
sum
influenc
function
influenc
function
th
subject
demnati
rao
prove
express
influenc
function
subject
z
ik
n
dt
influenc
function
k
th
subject
thu
deriv
